Characteristics of Young Infants in Whom Human Parechovirus, Enterovirus or Neither Were Detected in Cerebrospinal Fluid During Sepsis Evaluations

Background: Human parechovirus (HPeV) causes central nervous system (CNS) infection in infants. To further understand HPeV CNS infection, we describe its clinical, laboratory and epidemiologic characteristics from a Midwestern US tertiary care center. Because HPeV CNS infections have appeared clinically and seasonally similar to enterovirus (EV) infections, we retrospectively compared characteristics of young infants undergoing sepsis evaluations in whom HPeV, EV or neither were detected in cerebrospinal fluid (CSF). Methods: HPeV real-time reverse-transcription polymerase chain reaction (RT-PCR) assay was performed on frozen nucleic acid extracts of CSF specimens submitted for EV RT-PCR assay from children seen at our hospital in 2009. HPeV genotyping was performed by sequencing of the viral protein 1 region. Clinical data were abstracted from medical records retrospectively for EV-positive, HPeV-positive and age-matched controls in whom neither virus was detected from CSF testing. Results: HPeV was detected in 66 of the 388 (17%) CSF specimens whereas EV was detected in 54 of the 388 (14%) from June through October 2009. Genotyping identified HPeV3 in 51 of the 66 (77%) positive CSF specimens. Males predominated (61%) with the most common presenting symptoms (91%) being fever and irritability. All HPeV-positive patients were <5 months of age. Eight required admission to the pediatric intensive care unit. In multivariate analysis, lower peripheral white blood cell counts with lower absolute lymphocyte count values, higher maximum temperatures, longer fever duration, absence of pleocytosis and longer hospitalization were independently associated with HPeV patients compared with patients with EV or patients negative for both HPeV and EV. Conclusions: Our data indicate that HPeV3, an emerging CNS pathogen of infants in the United States, should be considered in sepsis-like presentation even without CSF pleocytosis. Addition of HPeV RT-PCR to EV RT-PCR assay for CSF specimens of patients <6 months of age could reduce hospital stay and costs while improving clinical management

[1]  Elliot J. Lefkowitz,et al.  Virus taxonomy: classification and nomenclature of viruses , 2012 .

[2]  L. Corey,et al.  Introduction of a novel parechovirus RT-PCR clinical test in a regional medical center. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  R. Selvarangan,et al.  Human Parechovirus 3 Causing Sepsis-like Illness in Children From Midwestern United States , 2011, The Pediatric infectious disease journal.

[4]  M. Pallansch,et al.  Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  J. P. Davis,et al.  Infant deaths associated with human parechovirus infection in Wisconsin. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  P. Simmonds,et al.  Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. , 2009, The Journal of infectious diseases.

[7]  Fumiaki Ito,et al.  Epidemic of human parechovirus type 3 in Hiroshima city, Japan in 2008. , 2009, Japanese journal of infectious diseases.

[8]  J. Drexler,et al.  Novel Human Parechovirus from Brazil , 2009, Emerging infectious diseases.

[9]  R. Molenkamp,et al.  High Prevalence of Human Parechovirus (HPeV) Genotypes in the Amsterdam Region and Identification of Specific HPeV Variants by Direct Genotyping of Stool Samples , 2008, Journal of Clinical Microbiology.

[10]  P. Simmonds,et al.  Epidemiology and Clinical Associations of Human Parechovirus Respiratory Infections , 2008, Journal of Clinical Microbiology.

[11]  M. Pallansch,et al.  Detection of All Known Parechoviruses by Real-Time PCR , 2008, Journal of Clinical Microbiology.

[12]  Floris Groenendaal,et al.  Severe Neonatal Parechovirus Infection and Similarity With Enterovirus Infection , 2008, The Pediatric infectious disease journal.

[13]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[14]  B. Berkhout,et al.  Human parechovirus infections in Dutch children and the association between serotype and disease severity. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  G. Boivin,et al.  Human Parechovirus 3 and Neonatal Infections , 2005, Emerging infectious diseases.

[16]  M. Kimura.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences , 1980, Journal of Molecular Evolution.

[17]  N. Takeda,et al.  Isolation and identification of a novel human parechovirus. , 2004, The Journal of general virology.

[18]  M. Abzug.  Presentation, Diagnosis, and Management of Enterovirus Infections in Neonates , 2004, Paediatric drugs.

[19]  L. Baraff.  Management of fever without source in infants and children. , 2000, Annals of emergency medicine.

[20]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[21]  P. Auvinen,et al.  A distinct picornavirus group identified by sequence analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.